Product details

By continuing to use our site you consent to the use of cookies as described in our privacy policy unless you have disabled them.
You can change your cookie settings at any time but parts of our site will not function correctly without them.
Case
-
Reference no. BAB043J
Japanese language
Published by: Babson College
Originally published in: 2003
Version: 6 Nov 2003

Abstract

This is a Japanese version. This case traces the development of the balanced scorecard for a fast- growing biotech company in transition. Reports how the new Chief Executive Officer embraces the scorecard concept early to explain and measure the progress of his strategic objectives to the various stakeholders. Subsequently traces the roll-out and development of the scorecards as they cascade throughout the organisation. Finally, the north American Chief Financial Officer confronts the problem of relating scorecard targets to the individual performance goals of his finance team.

About

Abstract

This is a Japanese version. This case traces the development of the balanced scorecard for a fast- growing biotech company in transition. Reports how the new Chief Executive Officer embraces the scorecard concept early to explain and measure the progress of his strategic objectives to the various stakeholders. Subsequently traces the roll-out and development of the scorecards as they cascade throughout the organisation. Finally, the north American Chief Financial Officer confronts the problem of relating scorecard targets to the individual performance goals of his finance team.

Related